PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
146.22%
Net income growth 1.25-1.5x CRK's 103.18%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
7.73%
Less D&A growth vs. CRK's 32.02%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-55.56%
Negative yoy deferred tax while CRK stands at 103.46%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
100.00%
SBC growth while CRK is negative at -29.81%. John Neff would see competitor possibly controlling share issuance more tightly.
22.40%
Slight usage while CRK is negative at -109.92%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
100.00%
AR growth while CRK is negative at -157.45%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.40%
Lower 'other working capital' growth vs. CRK's 93.17%. David Dodd would see fewer unexpected short-term demands on cash.
72.73%
Some yoy increase while CRK is negative at -88.12%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
104.11%
Some CFO growth while CRK is negative at -0.11%. John Neff would note a short-term liquidity lead over the competitor.
28.73%
Some CapEx rise while CRK is negative at -38.15%. John Neff would see competitor possibly building capacity while we hold back expansions.
-66.67%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-28.73%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-41.54%
We reduce yoy sales while CRK is 100.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
26.70%
We have some outflow growth while CRK is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
19.78%
We have mild expansions while CRK is negative at -37.92%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-57.23%
We cut debt repayment yoy while CRK is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.